Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer

Background: Breast cancer is the most common malignancy among women. It is estimated that 1 in 10 women worldwide is affected by breast cancer during their lifetime. In 5 to 10% of breast cancer patients, the disease results from a hereditary predisposition, which can be attributable to mutations in...

Full description

Bibliographic Details
Main Authors: Lamia Elfandi, Ghada Said, Saleh Suleiman Saleh, Mohamed Marwan, Nabil Enattah
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2016-03-01
Series:Archives of Breast Cancer
Subjects:
Online Access:https://archbreastcancer.com/index.php/abc/article/view/51
_version_ 1818056611703291904
author Lamia Elfandi
Ghada Said
Saleh Suleiman Saleh
Mohamed Marwan
Nabil Enattah
author_facet Lamia Elfandi
Ghada Said
Saleh Suleiman Saleh
Mohamed Marwan
Nabil Enattah
author_sort Lamia Elfandi
collection DOAJ
description Background: Breast cancer is the most common malignancy among women. It is estimated that 1 in 10 women worldwide is affected by breast cancer during their lifetime. In 5 to 10% of breast cancer patients, the disease results from a hereditary predisposition, which can be attributable to mutations in either of two tumor suppressor genes, BRCA1 and BRCA2 to a large extent. BRCA2 6174delT mutation constitutes the common mutant alleles which predispose to hereditary breast cancer in the Ashkenazi population with a reported carrier frequency of 1.52%. In this study, we investigated the presence of the 6174delT mutation of the BRCA2 gene in Libyan woman affected with breast cancer and compared the results with those of other population groups. Methods: Eighty- five Libyan women with breast cancer in additions to 5 relatives of the patients (healthy individuals) were recruited to this study. We obtained clinical information, family history, and peripheral blood for DNA extraction and analyzed the data using multiplex mutagenic polymerase chain reaction (MS-PCR) for detection of 6174delT mutation in the BRCA2 gene. Results: The 6174delT of the BRCA2 gene was not detected either in the 85 patients with breast cancer (18 with familial breast cancer and 67 with sporadic breast cancer) nor in the 5 healthy individuals. Conclusions: The present study showed that the 6174delT of the BRCA2 gene was not detectable using mutagenic PCR in the Libyan patients with breast cancer and can be considered to be exceedingly rare
first_indexed 2024-12-10T12:31:36Z
format Article
id doaj.art-f7968aa8943a4b3eb475fa735c9f4ffc
institution Directory Open Access Journal
issn 2383-0433
language English
last_indexed 2024-12-10T12:31:36Z
publishDate 2016-03-01
publisher Kaviani Breast Disease Institute
record_format Article
series Archives of Breast Cancer
spelling doaj.art-f7968aa8943a4b3eb475fa735c9f4ffc2022-12-22T01:48:49ZengKaviani Breast Disease InstituteArchives of Breast Cancer2383-04332016-03-013110.19187/abc.2016318-1350Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast CancerLamia Elfandi0Ghada Said1Saleh Suleiman Saleh2Mohamed Marwan3Nabil Enattah4School of Biological Sciences, The Libyan Academy, Tripoli, LibyaDepartment of Genetic Engineering, Biotechnology Research Center (BTRC), Twisha, Tripoli, LibyaDepartment of Genetic Engineering, Biotechnology Research Center (BTRC), Twisha, Tripoli, LibyaFaculty of Sciences, Tripoli University, Tripoli, LibyaDepartment of Genetic Engineering, Biotechnology Research Center (BTRC), Twisha, Tripoli, LibyaBackground: Breast cancer is the most common malignancy among women. It is estimated that 1 in 10 women worldwide is affected by breast cancer during their lifetime. In 5 to 10% of breast cancer patients, the disease results from a hereditary predisposition, which can be attributable to mutations in either of two tumor suppressor genes, BRCA1 and BRCA2 to a large extent. BRCA2 6174delT mutation constitutes the common mutant alleles which predispose to hereditary breast cancer in the Ashkenazi population with a reported carrier frequency of 1.52%. In this study, we investigated the presence of the 6174delT mutation of the BRCA2 gene in Libyan woman affected with breast cancer and compared the results with those of other population groups. Methods: Eighty- five Libyan women with breast cancer in additions to 5 relatives of the patients (healthy individuals) were recruited to this study. We obtained clinical information, family history, and peripheral blood for DNA extraction and analyzed the data using multiplex mutagenic polymerase chain reaction (MS-PCR) for detection of 6174delT mutation in the BRCA2 gene. Results: The 6174delT of the BRCA2 gene was not detected either in the 85 patients with breast cancer (18 with familial breast cancer and 67 with sporadic breast cancer) nor in the 5 healthy individuals. Conclusions: The present study showed that the 6174delT of the BRCA2 gene was not detectable using mutagenic PCR in the Libyan patients with breast cancer and can be considered to be exceedingly rarehttps://archbreastcancer.com/index.php/abc/article/view/51BRCA2 geneBreast cancerPolymorphisms6174delT
spellingShingle Lamia Elfandi
Ghada Said
Saleh Suleiman Saleh
Mohamed Marwan
Nabil Enattah
Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
Archives of Breast Cancer
BRCA2 gene
Breast cancer
Polymorphisms
6174delT
title Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
title_full Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
title_fullStr Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
title_full_unstemmed Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
title_short Analysis of 6174delT Mutation in BRCA2 Gene by Mutagenically Separated PCR Among Libyan Patients with Breast Cancer
title_sort analysis of 6174delt mutation in brca2 gene by mutagenically separated pcr among libyan patients with breast cancer
topic BRCA2 gene
Breast cancer
Polymorphisms
6174delT
url https://archbreastcancer.com/index.php/abc/article/view/51
work_keys_str_mv AT lamiaelfandi analysisof6174deltmutationinbrca2genebymutagenicallyseparatedpcramonglibyanpatientswithbreastcancer
AT ghadasaid analysisof6174deltmutationinbrca2genebymutagenicallyseparatedpcramonglibyanpatientswithbreastcancer
AT salehsuleimansaleh analysisof6174deltmutationinbrca2genebymutagenicallyseparatedpcramonglibyanpatientswithbreastcancer
AT mohamedmarwan analysisof6174deltmutationinbrca2genebymutagenicallyseparatedpcramonglibyanpatientswithbreastcancer
AT nabilenattah analysisof6174deltmutationinbrca2genebymutagenicallyseparatedpcramonglibyanpatientswithbreastcancer